Quick Takeaways
- Nantahala Capital Partners Limited Partnership filed SCHEDULE 13G/A for UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY).
- Disclosed ownership: 7.8%.
- Date of event: 30 Sep 2024.
Nantahala Capital Partners Limited Partnership - 30 Sep 2024 SCHEDULE 13G/A Report for UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY)
- Filing Manager
- Nantahala Capital Partners Limited Partnership
- Reporting Manager
- NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
- Symbol
- UNCY
- Shares outstanding
- 101,647,371 shares
- Disclosed Ownership
- 7,887,836 shares
- Ownership
- 7.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2024, 16:53:53 UTC
- Date of event
- 30 Sep 2024
- Next filing
- 20 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Partners Limited Partnership disclosed 7.8% ownership in UNICYCIVE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (UNCY) on 30 Sep 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2024, 16:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 7.8% | 7,887,836 | 0 | 7,887,836 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer Nantahala Capital Management, LLC |